Therapeutic Uses
Anticonvulsants (Anti-Epileptics)
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Rufinamide-15N,d2, 1795037-48-7
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 95 %
Hazard Compound
No -Refer MSDS for accurate information
Rufinamide-15N,d2 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Rufinamide-15N,d2 usage and description
Rufinamide is an antiepileptic medication that is used to treat seizures in patients with Lennox-Gastaut syndrome, a rare form of epilepsy. It works by reducing the abnormal electrical activity in the brain that causes seizures. Rufinamide 15N D2 is a stable isotope-labeled form of the drug, which is used in pharmacokinetic and pharmacodynamic studies to determine how the drug is metabolized and how it interacts with the body.
The chemical formula of Rufinamide 15N D2 is C10H7D2N3O, and its molecular weight is 190.22 g/mol. The drug is classified as a triazole derivative and has a half-life of approximately 6-10 hours. It is primarily metabolized by the liver and excreted in the urine.
Rufinamide 15N D2 is typically administered orally in tablet form, with dosages ranging from 200 mg to 1600 mg per day. It is important to follow the prescribed dosage and schedule to achieve the best results and avoid potential side effects.
Common side effects of Rufinamide include dizziness, fatigue, nausea, vomiting, and tremors. More serious side effects may include suicidal thoughts, depression, and allergic reactions. Patients should consult with their healthcare provider if they experience any side effects or have concerns about the medication.
Overall, Rufinamide 15N D2 is an important tool in the study of antiepileptic drugs and the treatment of Lennox-Gastaut syndrome. Its stable isotope-labeled form allows for more precise analysis of the drug's effects on the body, which can ultimately lead to better treatment options for patients.
